ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 23:20 (1652 d 12:00 ago) – Posting: # 20047
Views: 4,681

Hi Helmut,

Thank you so much for the detailed answer!

❝ ❝ Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

❝ Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}

Edit: Guidance linked. [Helmut]

Kind regards,

Complete thread:

UA Flag
 Admin contact
22,759 posts in 4,775 threads, 1,628 registered users;
25 visitors (0 registered, 25 guests [including 3 identified bots]).
Forum time: 12:21 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz